Author:
Wu Jonathan,Lim Ee-Chien,Nadkarni Nivedita V.,Tan Eng-King,Kumar Prakash M.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Alves, G., Forsaa, E. B., Pedersen, K. F., Dreetz, G. M. & Larsen, J. P. Epidemiology of Parkinson’s disease. J. Neurol. 255, 18–32 (2008).
2. GBD 2016 Parkinson’s disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 939-953 (2018).
3. Kianirad, Y. & Simuni, T. Novel Approaches to Optimization of Levodopa Therapy for Parkinson’s disease. Curr. Neurol. Neurosci. Rep. 16, 34,
https://doi.org/10.1007/s11910-016-0635-8
(2016).
4. Thanvi, B. R. & Lo, T. C. Long term motor complications of levodopa: clinical features, mechanisms, and management strategies. Postgrad. Med. J. 80, 452–458 (2004).
5. Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129–2170 (2008).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献